TCL Archive Clinical Oncology Programs Extended Two Years; No Decision Yet On Further Expansion November 3, 1978
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: Gigliotti Named Greenwald Special Assistant; Coltman To Get ACCC Clinical Research Award August 26, 1988
